周二，Piper Sandler在投资者和分析师会议后重申了对Nektar ...

Insulet (NASDAQ:PODD – Get Free Report) had its price objective boosted by analysts at Piper Sandler from $285.00 to $310.00 ...

Trupanion (NASDAQ:TRUP – Free Report) had its target price trimmed by Piper Sandler from $57.00 to $52.00 in a research ...

Piper Sandler Companies (PIPR) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in ...

In a report released today, Patrick Moley from Piper Sandler maintained a Buy rating on Nasdaq (NDAQ – Research Report), with a price target of $80.00. The company’s shares closed last Friday ...

Piper Sandler expressed continued confidence in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), maintaining an Overweight ...

Fintel reports that on January 6, 2025, Piper Sandler upgraded their outlook for Kenvue (NYSE:KVUE) from Neutral to Overweight. As of December 23, 2024, the average one-year price target for ...

Investing.com -- Piper Sandler upgraded Qorvo Inc (NASDAQ:QRVO) shares to "overweight" on potential operational and capital efficiencies driven by Starboard Value’s recent involvement.

Pets insurance company Trupanion (NASDAQ:TRUP) was upgraded at Piper Sandler on improving investor sentiment and several favorable catalysts. The catalysts include the 2025 guidance, faster-than ...

Piper Sandler analyst Joseph Catanzaro lowered the firm’s price target on Iovance Biotherapeutics (IOVA) to $7.50 from $10 and keeps a Neutral rating on the shares. Ahead of FY24 earnings ...